A large analysis of two major clinical trials has found that the spread of prostate cancer can be detected on imaging scans even when biomarkers remain stable in patients treated with androgen ...
Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical trials. A team at Heriot-Watt University, Edinburgh, leading the clinical ...
Science Daily: Advanced imaging uncovers hidden metastases in high-risk prostate cancer cases
The American Journal of Managed Care: PSMA PET and the Evolving Imaging Landscape in Prostate Cancer
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary biopsies and missed diagnoses. At Kennesaw State University, assistant ...
MSN: New imaging solution could help improve survival for patients with recurring prostate cancer
New imaging solution could help improve survival for patients with recurring prostate cancer
Renal & Urology News: PSMA-PET Imaging Alters Prostate Cancer Salvage Radiation Treatment
PSMA-PET molecular imaging more often triggers changes in salvage radiation treatment compared with usual care. Prostate-specific membrane antigen positron emission tomography (PSMA-PET) imaging ...
ascopubs.org: Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care
Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care
Nasdaq: Telix Pharma Launches New Prostate Cancer Imaging Agent, Gozellix, In U.S.
(RTTNews) - Telix Pharmaceuticals Limited (TLX, TLX.AX) announces that its next-generation PSMA-PET imaging agent for prostate cancer, Gozellix (kit for the preparation of gallium-68 (68Ga) gozetotide ...